Structure-activity relationships of some taxoids as multidrug resistance modulator

被引:7
作者
Hasegawa, Toshiaki
Bai, Jao
Zhang, Shujun
Wang, Jinlan
Matsubara, Junichi
Kawakami, Junichi
Tomida, Akihiro
Tsuruo, Takashi
Hirose, Katsutoshi
Sakai, Junichi
Kikuchi, Midori
Abe, Mariko
Ando, Masayoshi
机构
[1] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan
[2] Niigata Univ, Dept Chem & Chem Engn, Fac Engn, Niigata 9502181, Japan
[3] Mitsubishi Gas Chem Co Inc, Niigata Res Lab, Niigata 9503112, Japan
[4] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan
[5] Kobe Nat Prod & Chem Co Ltd, Kanzaki, Hyogo 6792315, Japan
关键词
taxoid; taxinine; 1,7-deoxy-4-deacetylbaccatin III; MDR; cytotoxicity;
D O I
10.1016/j.bmcl.2006.09.068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1,7-Deoxy-4-deacetylbaccatin III (12) and its five analogues 6-9, 13, and their oxetane ring opened derivatives 14, 16, and 17, which were synthesized from taxinine, showed significant activity as MDR reversal agent by the assay of the calcein accumulation toward MDR human ovarian cancer 2780AD cells. The most effective compound 12 in this assay is actually efficient for the recovery of cytotoxic activity of paclitaxel (taxol), adriamycin (ADM), and vincristine (VCR) toward MDR 2780AD cells at the same level toward parental 2780 cells. This activity of 12 is very interesting because baccatin 111 (4) has no such MDR reversal activity but has cytotoxic activity. The essential functional groups inducing such a difference in biological activity between 4 and 12 are 4 alpha-acetoxyl for 4 and 4 alpha-hydroxyl for 12. In seven compounds possessing MDR reversal activity, compound 12 is the most desirable compound for anti-MDR cancer reversal agent, because it has the highest accumulation ability of anticancer agent in MDR cancer cells and weak cytotoxic activity. Compounds 8 and 13 showed significant cytotoxic activity toward HepG2 and VA-13, respectively, as well as MDR reversal activity. They are expected to become lead compounds for new types of anticancer agent or anti-MDR cancer agent. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1122 / 1126
页数:5
相关论文
共 50 条
[21]   Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity [J].
Fu, Ying ;
Habtemariam, Abraha ;
Basri, Aida M. B. H. ;
Braddick, Darren ;
Clarkson, Guy J. ;
Sadler, Peter J. .
DALTON TRANSACTIONS, 2011, 40 (40) :10553-10562
[22]   Relationships between the structure, cytotoxicity and hydrophobicity of quinazoline derivatives by quantitative structure-activity relationship [J].
Jantova, S ;
Balaz, S ;
Stankovsky, S ;
Spirkova, K ;
Lukacova, V .
FOLIA BIOLOGICA, 1997, 43 (02) :83-89
[23]   Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel [J].
Uoto, K ;
Ohsuki, S ;
Takenoshita, H ;
Ishiyama, T ;
Iimura, S ;
Hirota, Y ;
Mitsui, I ;
Terasawa, H ;
Soga, T .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (11) :1793-1804
[24]   Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells [J].
Plochmann, Kathrin ;
Korte, Gabriele ;
Koutsilieri, Eleni ;
Richling, Elke ;
Riederer, Peter ;
Rethwilm, Axel ;
Schreier, Peter ;
Scheller, Carsten .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 460 (01) :1-9
[25]   Structure-Activity Relationships of 2-Benzylsulfanylbenzothiazoles: Synthesis and Selective Antimycobacterial Properties [J].
Klimesova, Vera ;
Koci, Jan ;
Palat, Karel ;
Stolarikova, Jirina ;
Dahse, Hans-Martin ;
Moellmann, Ute .
MEDICINAL CHEMISTRY, 2012, 8 (02) :281-292
[26]   Structure-Activity Relationships of the Bioactive Thiazinoquinone Marine Natural Products Thiaplidiaquinones A and B [J].
Harper, Jacquie L. ;
Khalil, Iman M. ;
Shaw, Lisa ;
Bourguet-Kondracki, Marie-Lise ;
Dubois, Joelle ;
Valentin, Alexis ;
Barker, David ;
Copp, Brent R. .
MARINE DRUGS, 2015, 13 (08) :5102-5110
[27]   Structure-activity relationships of novel heteroaryl-acrylonitriles as cytotoxic and antibacterial agents [J].
Saczewski, Franciszek ;
Stencel, Agnieszka ;
Bienczak, Andrzej M. ;
Langowska, Karolina A. ;
Michaelis, Martin ;
Werel, Wladyslaw ;
Halasa, Rafal ;
Reszka, Przemyslaw ;
Bednarski, Patrick J. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (09) :1847-1857
[28]   Quantitative Structure-Activity Relationships for Cellular Uptake of Surface-Modified Nanoparticles [J].
Liu, Rong ;
Rallo, Robert ;
Bilal, Muhammad ;
Cohen, Yoram .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (04) :365-375
[29]   Pharmacokinetics of multidrug resistance modulator FG020326 in mice [J].
Dai, Chunling ;
Fu, Li-wu .
ACTA PHARMACOLOGICA SINICA, 2006, 27 :208-208
[30]   Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421 [J].
Olszewski, Ulrike ;
Zeillinger, Robert ;
Kars, Meltem Demirel ;
Zalatnai, Attila ;
Molnar, Jozsef ;
Hamilton, Gerhard .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (06) :663-671